Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand(4)
添加时间:2010-08-02 原文发表:2010-08-02 人气:97
本文章共5793字,分4页,当前第4页,快速翻页:
The information contained in this press release is as of the date of this release. Abraxis assumes no obligations to update any forward-looking statements contained in this press release as the result of new information or future events or developments.
Contact: Investor and Media Inquiries
Pondel Wilkinson Inc.
Rob Whetstone
310-279-5963
or
Monsoon Communications
Emma Powers
Level 1 350 Collins Street
Melbourne VIC 3000
Ph: +613 9620 3333 www.monsoon.com.au